Apellis Pharmaceuticals (NASDAQ:APLS) Reaches New 52-Week Low on Analyst Downgrade
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) reached a new 52-week low on Wednesday after Mizuho lowered their price target on the stock from $30.00 to $20.00. Mizuho currently has a neutral rating on the stock. Apellis Pharmaceuticals traded as low as $16.61 and last traded at $16.69, with a volume of […]
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) reached a new 52-week low on Wednesday after Mizuho lowered their price target on the stock from $30.00 to $20.00. Mizuho currently has a neutral rating on the stock. Apellis Pharmaceuticals traded as low as $16.61 and last traded at $16.69, with a volume of […]
